ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

クロロキン二りん酸塩

Chloroquine Phosphate

HCID 64927
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
50-63-5
標準SMILES
CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.O=P(O)(O)O.O=P(O)(O)O
InChIKey
QKICWELGRMTQCR-UHFFFAOYSA-N
分子式
C18H32ClN3O8P2
平均分子量
515.9 g/mol
単同位体質量
515.1353167

概要

Chloroquine Phosphate is the phosphate salt of chloroquine, a quinoline compound with antimalarial and anti-inflammatory properties. Chloroquine is the most widely used drug against malaria, except for those cases caused by chloroquine resistant Plasmodium falciparum. Although the mechanism of action is not fully understood, chloroquine is shown to inhibit the parasitic enzyme heme polymerase that converts the toxic heme into non-toxic hemazoin, thereby resulting in the accumulation of toxic heme within the parasite. Chloroquine may also interfere with the biosynthesis of nucleic acids.

名称と識別子

優先名称
Chloroquine Phosphate
IUPAC
4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine;phosphoric acid
現地名
クロロキン二りん酸塩
英語名
Chloroquine diphosphate
分子式
C18H32ClN3O8P2
分子量
515.86

名称と別名

Chloroquine diphosphateChloroquine phosphateAralen phosphateArechinAvloclorResochinChingamin phosphateDelagilChloroquini phosphasNSC-140506E17K3343PSN-7618
名称をさらに表示
りん酸チンガミンタナカンクロロキンビスりん酸アレキンアラレンりん酸塩アレチンりん酸クロロキンレソキンビスりん酸塩チンガミンりん酸塩りん酸レソキンクロロキンホスファートクロロキンジホスファートりん酸アラレンクロロキン二りん酸クロロキンりん酸N'-(7-クロロキノリン-4-イル)-N,N-ジエチル-1,4-ペンタンジアミン·2りん酸塩デラギルサノキンクロロキンりん酸塩クロロキン二りん酸塩CHLOROQUIN PHOSPHATECHLOROQUINE DIPHOSPHATE SALTwr1522alermineh-stadurkhingaminMelatonine2klorokinfosfatChloropicrin 1
WR-15227-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline phosphate (1:2)1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2)N(4)-(7-Chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine, phosphate (1:2)khingamin phosphateNSC14050MalarivonChloroquinum Phos.

物性

構造計算による物性

極性表面積
184 Ų
水素結合供与体数
7
水素結合受容体数
11
回転可能結合数
8
重原子数
32
形式電荷
0
複雑度
358

実験および物理化学的性質

Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Anti-infective Agents; Antiparasitic Agents; Antimalarials; Antirheumatic Agents; Antiprotozoal Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsFDA approved animal drugs -> Active ingredient
Collision Cross Section175.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
200 °C · 200 °C (dec.) (lit.)
蒸気圧
1e-7 kPa · <0.0000001 kPa ( 25 °C)
貯蔵温度
protect from light
溶解性
2 O: · H2O: 50 mg/mL、透明
外見
個体
酸解離定数(Pka)
8.1 · pKa 8.10(H2O t = 20 c = 0.0025) (Uncertain)
色
白い
PH
pH(100g/l, 25℃) : 3.8~4.3
由来生物
synthetic
水溶解度
水に溶ける
Merck
14 · 14,2163
BRN
4223142 · 4223142

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Other Safety InformationIMAP assessments - 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, phosphate (1:2): Environment tier I assessment

毒性情報

Treatment · 1 件

Treatment is symptomatic and must be prompt with immediate evacuation of the stomach by emesis (at home, before transportation to the hospital) or gastric lavage until the stomach is completely emptied. If finely powdered, activated charcoal is introduced by stomach tube, after lavage, and within 30 minutes after ingestion of the antimalarial, it may inhibit further intestinal absorption of the drug. To be effective, the dose of activated charcoal should be at least five times the estimated dose of chloroquine ingested. Convulsions, if present, should be controlled before attempting gastric lavage. (L1712)

Health Effects · 1 件

Possible heath effects include an irreversible retinal damage, visual disturbances, nyctalopia; scotomatous vision with field defects of paracentral, pericentral ring types, and typically temporal scotomas, nerve type deafness; tinnitus, reduced hearing in patients with preexisting auditory damage. Other effects include pleomorphic skin eruptions, skeletal muscle myopathy, hypotension, electrocardiographic change as well as neuropsychiatric changes including psychosis, delirium, personality changes and depression (RxList, A308).

Exposure RoutesInhalation Completely absorbed from gastrointestinal tract
Toxicity Summary · 1 件

The mechanism of plasmodicidal action of chloroquine is not completely certain. Like other quinoline derivatives, it is thought to inhibit heme polymerase activity. This results in accumulation of free heme, which is toxic to the parasites. nside red blood cells, the malarial parasite must degrade hemoglobin to acquire essential amino acids, which the parasite requires to construct its own protein and for energy metabolism. Digestion is carried out in a vacuole of the parasite cell. During this process, the parasite produces the toxic and soluble molecule heme. The heme moiety consists of a porphyrin ring called Fe(II)-protoporphyrin IX (FP). To avoid destruction by this molecule, the parasite biocrystallizes heme to form hemozoin, a non-toxic molecule. Hemozoin collects in the digestive vacuole as insoluble crystals. Chloroquine enters the red blood cell, inhabiting parasite cell, and digestive vacuole by simple diffusion. Chloroquine then becomes protonated (to CQ2+), as the digestive vacuole is known to be acidic (pH 4.7); chloroquine then cannot leave by diffusion. Chloroquine caps hemozoin molecules to prevent further biocrystallization of heme, thus leading to heme buildup. Chloroquine binds to heme (or FP) to form what is known as the FP-Chloroquine complex; this complex is highly toxic to the cell and disrupts membrane function. Action of the toxic FP-Chloroquine and FP results in cell lysis and ultimately parasite cell autodigestion. In essence, the parasite cell drowns in its own metabolic products.

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Completely absorbed from gastrointestinal tract. Chloroquine is partially metabolized; the major metabolite is desethylchloroquine. Desethylchloroquine also has antiplasmodial activity, but is slightly less active than chloroquine. Bisdesethylchloroquine, which is a carboxylic acid derivative, and several other unidentified metabolites are also formed in small amounts (A625). Route of Elimination: Excretion of chloroquine is quite slow, but is increased by acidification of the urine. Half Life: 1-2 months

FDA Pharmacological Classification · 4 件

CHLOROQUINE PHOSPHATE

Antimalarial [EPC]

CHLOROQUINUM PHOS.

Antimalarial [EPC]

MeSH Pharmacological Classification · 3 件

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)

Pharmacological agents destructive to nematodes in the superfamily Filarioidea.

用途と製造

UsesFor the suppressive treatment and for acute attacks of malaria due to P. vivax, P.malariae, P. ovale, and susceptible strains of P. falciparum, Second-line agent in treatment of Rheumatoid Arthritis (A308).
Household ProductsInformation on 1 consumer products that contain Chloroquine phosphate in the following categories is provided:

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
50-63-5
PubChem CID
64927
DTXSID
DTXSID7044681
ChEMBL
CHEMBL58510
UNII
6E17K3343P
BCS Class
1 · 1
安定性
2 · 購入日から2年間安定です。この蒸留水溶液は、-20°C で 3 か月間保存できます。
InChI
1S/C18H26ClN3.2H3O4P/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18;2*1-5(2,3)4/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21);2*(H3,1,2,3,4)
InChIKey
QKICWELGRMTQCR-UHFFFAOYSA-N
SMILES
OP(O)(O)=O.OP(O)(O)=O.CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
CAS データベース
50 · 50-63-5(CAS DataBase Reference)
EPAの化学物質情報
Chloroquine diphosphate (50-63-5)

化学的性質

化学的特性White Solid

Signs and SymptomsConvulsive seizures. Mild and transient headache.
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Chloroquine phosphate

vLess-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

安全データ

F
10
wgk
3
rtecs
VB2450000
ridadr
1544
毒性
LD50 oral in rat: 623mg/kg
hs_code
2933492250
risk_code
22-40-20/21/22
化審法
(9)-279
hazard_code
Xn
safety_code
22-24/25-36
hazard_class
6.1(b)
packing_group
III
Hazard Classifications
Acute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids
応用分野 · 4 件

用途抗マラリア剤として作用しま す。

用途薬理・生理作用研究用。

使用Chloroquine diphosphate salt is used to study the role of endosomal acidification in cellular processes, such as the signaling of intracellular TLRs. It can be used as DNA intercalator & to dissociate antigen antibody complexes without denaturing red blood cell antigens. Chloroquine showed very high antiviral activity against NiV but very little activity against the other viruses at concentrations lower than 20 μM.

一般的な説明Chloroquine phosphate is a phosphate salt of chloroquine. It belongs to the class of aminoquinoline drugs utilized as antimalarials and amebicides.

上流・下流製品情報

上流原料

4-アミノ-1-ジエチルアミノペンタン4,7-ジクロロキノリンりん酸